| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | metalloendopeptidase activity | 1.97e-04 | 120 | 48 | 4 | GO:0004222 | |
| GeneOntologyMolecularFunction | SH3 domain binding | 3.84e-04 | 143 | 48 | 4 | GO:0017124 | |
| GeneOntologyBiologicalProcess | positive regulation of protein secretion | 6.40e-06 | 194 | 49 | 6 | GO:0050714 | |
| GeneOntologyBiologicalProcess | regulation of adherens junction organization | 5.50e-05 | 5 | 49 | 2 | GO:1903391 | |
| GeneOntologyBiologicalProcess | positive regulation of protein transport | 1.04e-04 | 319 | 49 | 6 | GO:0051222 | |
| Domain | Peptidase_M12B_N | 2.96e-06 | 39 | 48 | 4 | IPR002870 | |
| Domain | Pep_M12B_propep | 2.96e-06 | 39 | 48 | 4 | PF01562 | |
| Domain | DISINTEGRIN_1 | 3.28e-06 | 40 | 48 | 4 | PS00427 | |
| Domain | Reprolysin | 3.28e-06 | 40 | 48 | 4 | PF01421 | |
| Domain | ADAM_MEPRO | 3.28e-06 | 40 | 48 | 4 | PS50215 | |
| Domain | DISINTEGRIN_2 | 3.28e-06 | 40 | 48 | 4 | PS50214 | |
| Domain | Peptidase_M12B | 3.28e-06 | 40 | 48 | 4 | IPR001590 | |
| Domain | Disintegrin_dom | 3.63e-06 | 41 | 48 | 4 | IPR001762 | |
| Domain | Transcription_factor_COE | 3.87e-05 | 4 | 48 | 2 | IPR003523 | |
| Domain | COE_HLH | 3.87e-05 | 4 | 48 | 2 | IPR032201 | |
| Domain | COE_DBD | 3.87e-05 | 4 | 48 | 2 | IPR032200 | |
| Domain | Transcription_factor_COE_CS | 3.87e-05 | 4 | 48 | 2 | IPR018350 | |
| Domain | COE1_HLH | 3.87e-05 | 4 | 48 | 2 | PF16423 | |
| Domain | COE1_DBD | 3.87e-05 | 4 | 48 | 2 | PF16422 | |
| Domain | COE | 3.87e-05 | 4 | 48 | 2 | PS01345 | |
| Domain | ACR | 4.46e-05 | 27 | 48 | 3 | SM00608 | |
| Domain | ADAM_Cys-rich | 4.46e-05 | 27 | 48 | 3 | IPR006586 | |
| Domain | MetalloPept_cat_dom | 5.52e-05 | 81 | 48 | 4 | IPR024079 | |
| Domain | - | 5.52e-05 | 81 | 48 | 4 | 3.40.390.10 | |
| Domain | ZINC_PROTEASE | 1.16e-04 | 98 | 48 | 4 | PS00142 | |
| Domain | - | 2.60e-04 | 663 | 48 | 8 | 2.60.40.10 | |
| Domain | Ig-like_fold | 3.96e-04 | 706 | 48 | 8 | IPR013783 | |
| Domain | Disintegrin_CS | 7.58e-04 | 16 | 48 | 2 | IPR018358 | |
| Domain | ADAM_CR | 9.64e-04 | 18 | 48 | 2 | PF08516 | |
| Domain | - | 1.19e-03 | 20 | 48 | 2 | 4.10.70.10 | |
| Domain | Disintegrin | 1.32e-03 | 21 | 48 | 2 | PF00200 | |
| Domain | DISIN | 1.32e-03 | 21 | 48 | 2 | SM00050 | |
| Domain | ADAM_spacer1 | 1.58e-03 | 23 | 48 | 2 | IPR010294 | |
| Domain | ADAM_spacer1 | 1.58e-03 | 23 | 48 | 2 | PF05986 | |
| Domain | Peptidase_M12B_ADAM-TS | 1.72e-03 | 24 | 48 | 2 | IPR013273 | |
| Domain | IPT | 2.18e-03 | 27 | 48 | 2 | SM00429 | |
| Domain | TIG | 2.87e-03 | 31 | 48 | 2 | PF01833 | |
| Domain | Spectrin/alpha-actinin | 3.05e-03 | 32 | 48 | 2 | IPR018159 | |
| Domain | IPT | 3.05e-03 | 32 | 48 | 2 | IPR002909 | |
| Domain | SPEC | 3.05e-03 | 32 | 48 | 2 | SM00150 | |
| Domain | EGF | 3.08e-03 | 235 | 48 | 4 | SM00181 | |
| Domain | GDS_CDC24_CS | 4.51e-03 | 39 | 48 | 2 | IPR001331 | |
| Domain | PDZ | 5.68e-03 | 141 | 48 | 3 | PF00595 | |
| Domain | PDZ | 6.50e-03 | 148 | 48 | 3 | SM00228 | |
| Domain | - | 6.74e-03 | 150 | 48 | 3 | 2.30.42.10 | |
| Domain | PDZ | 6.87e-03 | 151 | 48 | 3 | PS50106 | |
| Domain | PDZ | 6.99e-03 | 152 | 48 | 3 | IPR001478 | |
| Domain | IG_LIKE | 8.31e-03 | 491 | 48 | 5 | PS50835 | |
| Domain | Ig-like_dom | 9.17e-03 | 503 | 48 | 5 | IPR007110 | |
| Pubmed | 2.19e-06 | 2 | 52 | 2 | 23833070 | ||
| Pubmed | A dual-activity topoisomerase complex regulates mRNA translation and turnover. | NCOA6 UBN1 TRIO ADAMTS7 KCNQ2 ARHGAP17 LTBP3 SNAPC4 DENND1A ARSG | 4.73e-06 | 1105 | 52 | 10 | 35748872 |
| Pubmed | 6.57e-06 | 3 | 52 | 2 | 29925039 | ||
| Pubmed | Cloning of a novel Olf-1/EBF-like gene, O/E-4, by degenerate oligo-based direct selection. | 1.31e-05 | 4 | 52 | 2 | 12139918 | |
| Pubmed | ADAM10 is a principal 'sheddase' of the low-affinity immunoglobulin E receptor CD23. | 2.19e-05 | 5 | 52 | 2 | 17072319 | |
| Pubmed | The enzymatic activity of ADAM8 and ADAM9 is not regulated by TIMPs. | 2.19e-05 | 5 | 52 | 2 | 12135759 | |
| Pubmed | 2.19e-05 | 5 | 52 | 2 | 15261831 | ||
| Pubmed | 3.28e-05 | 6 | 52 | 2 | 9676189 | ||
| Pubmed | Shedding of collagen XVII/BP180 in skin depends on both ADAM10 and ADAM9. | 3.28e-05 | 6 | 52 | 2 | 19574220 | |
| Pubmed | Extracellular matrix secretion by cardiac fibroblasts: role of microRNA-29b and microRNA-30c. | 3.50e-05 | 248 | 52 | 5 | 24006456 | |
| Pubmed | Ebf factors and MyoD cooperate to regulate muscle relaxation via Atp2a1. | 4.58e-05 | 7 | 52 | 2 | 24786561 | |
| Pubmed | 4.58e-05 | 7 | 52 | 2 | 15907280 | ||
| Pubmed | Trio GEF mediates RhoA activation downstream of Slit2 and coordinates telencephalic wiring. | 6.10e-05 | 8 | 52 | 2 | 30177526 | |
| Pubmed | 6.10e-05 | 8 | 52 | 2 | 14565974 | ||
| Pubmed | 6.10e-05 | 8 | 52 | 2 | 17344430 | ||
| Pubmed | 9.79e-05 | 10 | 52 | 2 | 11167130 | ||
| Pubmed | Zinc transporter Slc39a8 is essential for cardiac ventricular compaction. | 1.20e-04 | 11 | 52 | 2 | 29337306 | |
| Pubmed | Transient and lineage-restricted requirement of Ebf3 for sternum ossification. | 1.43e-04 | 12 | 52 | 2 | 32398354 | |
| Pubmed | 1.43e-04 | 12 | 52 | 2 | 30658714 | ||
| Pubmed | Insights on ADAMTS proteases and ADAMTS-like proteins from mammalian genetics. | 1.43e-04 | 12 | 52 | 2 | 25770910 | |
| Pubmed | A central chaperone-like role for 14-3-3 proteins in human cells. | 2.82e-04 | 861 | 52 | 7 | 36931259 | |
| Pubmed | 2.94e-04 | 17 | 52 | 2 | 10464288 | ||
| Pubmed | 3.30e-04 | 18 | 52 | 2 | 9152011 | ||
| Pubmed | A genome-wide association study of chemotherapy-induced alopecia in breast cancer patients. | 4.52e-04 | 21 | 52 | 2 | 24025145 | |
| Pubmed | 5.46e-04 | 251 | 52 | 4 | 29031500 | ||
| Pubmed | 5.93e-04 | 24 | 52 | 2 | 20826655 | ||
| Pubmed | 5.93e-04 | 24 | 52 | 2 | 25825872 | ||
| Pubmed | 8.67e-04 | 29 | 52 | 2 | 23499423 | ||
| Pubmed | 8.67e-04 | 29 | 52 | 2 | 30692221 | ||
| Pubmed | Semaphorin 3E/PlexinD1 signaling is required for cardiac ventricular compaction. | 1.06e-03 | 32 | 52 | 2 | 31434798 | |
| Pubmed | 1.06e-03 | 32 | 52 | 2 | 23049088 | ||
| Pubmed | The splicing regulator Rbfox2 is required for both cerebellar development and mature motor function. | 1.12e-03 | 33 | 52 | 2 | 22357600 | |
| Pubmed | SLX4IP acts with SLX4 and XPF-ERCC1 to promote interstrand crosslink repair. | 1.19e-03 | 34 | 52 | 2 | 31495888 | |
| Pubmed | Large-scale analysis of ion channel gene expression in the mouse heart during perinatal development. | 1.20e-03 | 139 | 52 | 3 | 16985003 | |
| Pubmed | Links between alpha-catenin, NF-kappaB, and squamous cell carcinoma in skin. | 1.26e-03 | 35 | 52 | 2 | 16452166 | |
| Pubmed | 1.27e-03 | 808 | 52 | 6 | 20412781 | ||
| Pubmed | Mutation of ARHGAP9 in patients with coronary spastic angina. | 1.49e-03 | 38 | 52 | 2 | 19911011 | |
| Cytoband | 20q13.3 | 2.36e-04 | 20 | 52 | 2 | 20q13.3 | |
| Cytoband | 17p11.2 | 7.95e-04 | 159 | 52 | 3 | 17p11.2 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr17p11 | 1.60e-03 | 203 | 52 | 3 | chr17p11 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr1p13 | 1.79e-03 | 211 | 52 | 3 | chr1p13 | |
| Cytoband | 1p13.3 | 2.81e-03 | 69 | 52 | 2 | 1p13.3 | |
| GeneFamily | ADAM metallopeptidases with thrombospondin type 1 motif | 7.58e-04 | 19 | 39 | 2 | 50 | |
| GeneFamily | ADAM metallopeptidase domain containing|CD molecules | 1.54e-03 | 27 | 39 | 2 | 47 | |
| GeneFamily | PDZ domain containing | 4.27e-03 | 152 | 39 | 3 | 1220 | |
| GeneFamily | Fibronectin type III domain containing | 4.92e-03 | 160 | 39 | 3 | 555 | |
| GeneFamily | Blood group antigens|CD molecules|I-set domain containing|Immunoglobulin like domain containing | 5.01e-03 | 161 | 39 | 3 | 593 | |
| GeneFamily | Pleckstrin homology domain containing|Rho guanine nucleotide exchange factors|C2 domain containing | 8.91e-03 | 66 | 39 | 2 | 722 | |
| ToppCell | Brain_organoid-organoid_Tanaka_cellReport-10w-Neuronal-Neuron|10w / Sample Type, Dataset, Time_group, and Cell type. | 3.62e-06 | 200 | 52 | 5 | 332905a686356cd1e024d40679be98e9d8b1b5e8 | |
| ToppCell | 368C-Lymphocytic-CD4_T-cell-Treg_cell_1|368C / Donor, Lineage, Cell class and subclass (all cells) | 2.69e-05 | 148 | 52 | 4 | 80470353e12599440f711b6e107730763376d04d | |
| ToppCell | droplet-Liver-LIVER-NPC-1m-Lymphocytic-B_cell|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.07e-05 | 153 | 52 | 4 | a8f83ec640fae51d4fba34b92e3d6cca4999e930 | |
| ToppCell | COVID-19_Severe-Treg|World / disease group, cell group and cell class | 3.74e-05 | 161 | 52 | 4 | c6eade2c60c572d823e6e81b5e8d47078671e9b0 | |
| ToppCell | E18.5-Immune-Immune_Lymphocytic_T/NK-Lymphocytic_B-B-B_mature|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 3.83e-05 | 162 | 52 | 4 | 59f6a9005c4f22f084c25ea36f3cacce5144a9ae | |
| ToppCell | 343B-Fibroblasts-Fibroblast-D-|343B / Donor, Lineage, Cell class and subclass (all cells) | 3.93e-05 | 163 | 52 | 4 | 8d2b2119c6b3d5b677da6f377fd85146590e1246 | |
| ToppCell | droplet-Liver-LIVER-NPC-1m-Lymphocytic-B_cell|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.93e-05 | 163 | 52 | 4 | 66ecd544d7b52e61880b125bf39d1f406af6900a | |
| ToppCell | 343B-Fibroblasts-Fibroblast-D|343B / Donor, Lineage, Cell class and subclass (all cells) | 3.93e-05 | 163 | 52 | 4 | acfb2ece6202479e615d54fd3ecb8b4a571b5a18 | |
| ToppCell | severe-Lymphocytic-B_cells_2|severe / Cohort 2 (Rhapsody WB + PBMC) with disease condition, lineage and cell classs | 4.02e-05 | 164 | 52 | 4 | a1031e9f945a15186ee14c12be47aa11c3c6583b | |
| ToppCell | 390C-Lymphocytic-ILC|390C / Donor, Lineage, Cell class and subclass (all cells) | 4.02e-05 | 164 | 52 | 4 | b0fc63b72162b5cc4d1e0a271a12f3d3ab29398f | |
| ToppCell | mild_COVID-19_(asymptomatic)-CD4+_T_naive|mild_COVID-19_(asymptomatic) / disease group, cell group and cell class (v2) | 4.31e-05 | 167 | 52 | 4 | 78d264af390bd89942ffbb2991dc94f50756d4c9 | |
| ToppCell | COVID-19_Severe-Treg|COVID-19_Severe / disease group, cell group and cell class | 4.62e-05 | 170 | 52 | 4 | d61269a51283125835884c4aa50623756c4fdda2 | |
| ToppCell | droplet-Liver-LIVER_NPC-30m-Lymphocytic-B_cell|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.73e-05 | 171 | 52 | 4 | 20ac3de9c164b409b70a30a8b6544ea491ef7c0e | |
| ToppCell | 3'-Broncho-tracheal-Mesenchymal-Fibroblastic-fibroblastic_type_1-Adventitial_fibroblasts-|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 4.84e-05 | 172 | 52 | 4 | e37c0b5b547a7345179ab258dd2141fec7064c17 | |
| ToppCell | facs-Trachea-nan-24m-Mesenchymal-chondrocyte|Trachea / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.95e-05 | 173 | 52 | 4 | 2226505610af1becc253d0a5550627144ef0ed6b | |
| ToppCell | kidney_cells-Hypertensive_with+without-CKD-Mesenchymal-glomerular_mesenchymal_cell-Mesangial_Cell-mesangial_typical-aged|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 5.18e-05 | 175 | 52 | 4 | 1b4cefae400bf756d09ece32d3f5c0bd4c6ad73f | |
| ToppCell | facs-Trachea-24m-Mesenchymal-myofibroblast-tracheobronchial_smooth_muscle_cell|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 5.18e-05 | 175 | 52 | 4 | f1394aacc8a94ca555dd19aaed5a18da99c6bf40 | |
| ToppCell | facs-Trachea-24m-Mesenchymal-myofibroblast|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 5.18e-05 | 175 | 52 | 4 | 7bf1194d93fbe2dbf9d953e0a32b2a6d88251ed1 | |
| ToppCell | PND14-Immune-Immune_Lymphocytic_T/NK-Lymphocytic_B-B|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 5.53e-05 | 178 | 52 | 4 | 8d74c12c4b0ce8bcb0f59151bdc67036997095ef | |
| ToppCell | PND14-Immune-Immune_Lymphocytic_T/NK-Lymphocytic_B-B-B_mature|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 5.53e-05 | 178 | 52 | 4 | 8ef229f38aa8a2ae8b366c3ce26d4cb1302d674a | |
| ToppCell | PND14-Immune-Immune_Lymphocytic_T/NK-Lymphocytic_B|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 5.53e-05 | 178 | 52 | 4 | 525c4b3f9736ff206e2f1378c2a29ba4f13ba22f | |
| ToppCell | facs-Lung-Endomucin-3m-Lymphocytic-B_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.65e-05 | 179 | 52 | 4 | de3245e1ee269e422de0308d0dd3623e4e9eb182 | |
| ToppCell | facs-Lung-Endomucin-3m-Lymphocytic-B_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.65e-05 | 179 | 52 | 4 | c41c11171dfb40e5ddea6bf97d9373eb03a2321b | |
| ToppCell | facs-Lung-3m-Mesenchymal-fibroblast-adventitial_fibroblast-adventitial_fibroblast_l17|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 5.77e-05 | 180 | 52 | 4 | 39ae8586efd91536e9ac6408d26de7e6d6237c41 | |
| ToppCell | COVID-19-Heart-Fib_+_EC_+_Pericyte|COVID-19 / Disease (COVID-19 only), tissue and cell type | 6.03e-05 | 182 | 52 | 4 | fbd5e332df73bf7141c822fa67b76367dc962017 | |
| ToppCell | Children_(3_yrs)-Epithelial-alveolar_epithelial_cell_type_2/Club-like_(AT2/Club-like)-D139|Children_(3_yrs) / Lineage, Cell type, age group and donor | 6.29e-05 | 184 | 52 | 4 | 102105ae1a5ef6d42a43f6d9b00f12ed0690ddb7 | |
| ToppCell | COVID-19-Heart-Fib_2|COVID-19 / Disease (COVID-19 only), tissue and cell type | 6.42e-05 | 185 | 52 | 4 | 8f95d8e591bf7379d13f5a0545b0cb49e2b1ab5d | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Immune-Lymphocytic_T/NK|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 6.56e-05 | 186 | 52 | 4 | 9d576dce2c5deefef1adda16c6da7055c8d57f8f | |
| ToppCell | Mild-Lymphoid-T-NK|Mild / Condition, Lineage, Cell class and cell subclass | 6.56e-05 | 186 | 52 | 4 | ed37a2df547661d22c1ed0b30cb1c19e489d9d0a | |
| ToppCell | kidney_cells-Adult_normal_reference-Mesenchymal-glomerular_mesenchymal_cell-Mesangial_Cell-mesangial_typical|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 6.69e-05 | 187 | 52 | 4 | d591a3c216997663ab77710fed0d230ffc37e41a | |
| ToppCell | kidney_cells-Adult_normal_reference-Mesenchymal-glomerular_mesenchymal_cell-Mesangial_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 6.69e-05 | 187 | 52 | 4 | d1dc8c9a2c2cd10c640257161a75e7730ec5bb41 | |
| ToppCell | kidney_cells-Adult_normal_reference-Mesenchymal-glomerular_mesenchymal_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 6.69e-05 | 187 | 52 | 4 | ac8e092b37e042975e2ee057d3f7c6821e58e8b5 | |
| ToppCell | Endothelial-Endothelial-E|Endothelial / shred on cell class and cell subclass (v4) | 6.83e-05 | 188 | 52 | 4 | 2777eb7689b271c199021fe7d9db88ccebff14de | |
| ToppCell | COVID-19-Heart-Fib_1|COVID-19 / Disease (COVID-19 only), tissue and cell type | 6.83e-05 | 188 | 52 | 4 | fe361215f4ba841aa5e1e581fb56f2f4d3ccd201 | |
| ToppCell | facs-Marrow-T-cells-3m-Lymphocytic-naive_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.83e-05 | 188 | 52 | 4 | 1f07e3ab87173426fe0c429f5c084fb3425effd3 | |
| ToppCell | facs-Marrow-T-cells-3m-Lymphocytic-naive_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.83e-05 | 188 | 52 | 4 | 85746f95319e494efdc1bbc24331698688d3a900 | |
| ToppCell | droplet-Lung-LUNG-1m-Mesenchymal-adventitial_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.98e-05 | 189 | 52 | 4 | f0a2d4ef9896d764971ebbc6952510c128bb76e8 | |
| ToppCell | droplet-Lung-LUNG-1m-Mesenchymal-Adventitial_Fibroblast|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.98e-05 | 189 | 52 | 4 | 378f26f751ab4b470948c35dd8347de72dd12ff7 | |
| ToppCell | droplet-Lung-18m-Endothelial-lymphatic_endothelial-lymphatic_endothelial_cell|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 7.12e-05 | 190 | 52 | 4 | e80d66ba0d5c263e94c1ab0b89d1dc7b837af3e1 | |
| ToppCell | droplet-Lung-18m-Endothelial-lymphatic_endothelial-lymphatic_endothelial_cell-lymphatic_endothelial_cell|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 7.12e-05 | 190 | 52 | 4 | f32d66c0e74e0a2a23ecb857c4daf0d8573a806c | |
| ToppCell | droplet-Lung-18m-Endothelial-lymphatic_endothelial|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 7.12e-05 | 190 | 52 | 4 | b79ffd05806244a9790cd04c66fb4f92c824e69f | |
| ToppCell | COVID_vent-Lymphocytic-B_cell|COVID_vent / Disease condition, Lineage, Cell class and subclass | 7.12e-05 | 190 | 52 | 4 | 40b5e9e8f8fd8d84cb5b43e67b49267082348e9f | |
| ToppCell | COVID_vent-Lymphocytic-B_cell-|COVID_vent / Disease condition, Lineage, Cell class and subclass | 7.12e-05 | 190 | 52 | 4 | a37a32dc1b931562a6660074e19d5598efc65284 | |
| ToppCell | PND01-Mesenchymal-Mesenchymal_structural-Fibroblastic-AF2|PND01 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 7.27e-05 | 191 | 52 | 4 | db4943dd19207663fb9e27f8940fa4b06a933625 | |
| ToppCell | LV-02._Fibroblast_II|World / Chamber and Cluster_Paper | 7.27e-05 | 191 | 52 | 4 | d36565257ccba8c1bbed2c1c01be66a9cbb5f834 | |
| ToppCell | 343B-Lymphocytic-NK_cells-NK_cell_D|343B / Donor, Lineage, Cell class and subclass (all cells) | 7.27e-05 | 191 | 52 | 4 | 2bd4ba4aaa0f4885079516156b409df527ab22f4 | |
| ToppCell | facs-Marrow-T-cells-3m-Lymphocytic-immature_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.41e-05 | 192 | 52 | 4 | 2de242d81dc085ae734eb7d1f091af9a542e0866 | |
| ToppCell | RV-01._Fibroblast_I|RV / Chamber and Cluster_Paper | 7.41e-05 | 192 | 52 | 4 | 356160b113c3305a61ceeaff33ce3c9da0be2878 | |
| ToppCell | facs-Limb_Muscle-ForelimbandHindlimb-3m-Mesenchymal-mesenchymal_stem_cell|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.41e-05 | 192 | 52 | 4 | beac6b3c191b11add8e39e8d04562b478ea8929e | |
| ToppCell | facs-Marrow-T-cells-3m-Lymphocytic-immature_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.41e-05 | 192 | 52 | 4 | ba2a683472a8b785dbf666dc6e94356d879486c3 | |
| ToppCell | LV-01._Fibroblast_I|LV / Chamber and Cluster_Paper | 7.56e-05 | 193 | 52 | 4 | dc17f3b9758936d428cf17f77a1ce6d4c479b165 | |
| ToppCell | RV-02._Fibroblast_II|RV / Chamber and Cluster_Paper | 7.72e-05 | 194 | 52 | 4 | 11c79a8c56ece42713b04b321982e41e239f07a5 | |
| ToppCell | COVID-19-lung-NK_cells|COVID-19 / Disease (COVID-19 only), tissue and cell type | 7.72e-05 | 194 | 52 | 4 | 4c92f18e0a34fb50630d4b260eaf179202508b6d | |
| ToppCell | 10x_3'_v2v3-Neoplastic-Differentiated-like-AC-like-AC-like-E|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 7.72e-05 | 194 | 52 | 4 | 8b81f039f5b25d35a4d5a41b27d4d9360ba22f15 | |
| ToppCell | LA-02._Fibroblast_II|LA / Chamber and Cluster_Paper | 7.72e-05 | 194 | 52 | 4 | 234d1494c114cce77c619708bbcd8d5ce805f19b | |
| ToppCell | 3'-Distal_airway-Immune_Lymphocytic-Lymphocytic_T/NK|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 7.87e-05 | 195 | 52 | 4 | e1b7ef4ba2ab14d3c839b6305d91efcfd0826220 | |
| ToppCell | 343B-Lymphocytic-NK_cells-NK_cell_A|343B / Donor, Lineage, Cell class and subclass (all cells) | 7.87e-05 | 195 | 52 | 4 | 1af6fd96634236d5910fd085ff2d532862303d6b | |
| ToppCell | COVID-19-Heart-Fib_1|Heart / Disease (COVID-19 only), tissue and cell type | 7.87e-05 | 195 | 52 | 4 | f423baa36ac7cdc383c033e35a7d17e6bf913323 | |
| ToppCell | 3'-Distal_airway-Immune_Lymphocytic|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 7.87e-05 | 195 | 52 | 4 | 4a60b51f92830882872f2fe1a911db2970faf071 | |
| ToppCell | COVID-19-lung-NK_cells|lung / Disease (COVID-19 only), tissue and cell type | 7.87e-05 | 195 | 52 | 4 | 3b716ec7acc9a37af6bf40e711a539ce58d74aa4 | |
| ToppCell | LA-02._Fibroblast_II|World / Chamber and Cluster_Paper | 7.87e-05 | 195 | 52 | 4 | a78b605b49acd8c9d68716266ca269dafcd910b9 | |
| ToppCell | control-Lymphocytic-B_cells_1|Lymphocytic / Cohort 2 (Rhapsody WB + PBMC) with disease condition, lineage and cell classs | 7.87e-05 | 195 | 52 | 4 | ff7956624b36df34e55295b295a71585accf07bd | |
| ToppCell | Children_(3_yrs)-Epithelial-club_cell-D032|Children_(3_yrs) / Lineage, Cell type, age group and donor | 7.87e-05 | 195 | 52 | 4 | dccc32fcf772e2504de7f663ef0a5bd8e23e92fc | |
| ToppCell | RV-02._Fibroblast_II|World / Chamber and Cluster_Paper | 7.87e-05 | 195 | 52 | 4 | ce90b30dcdb56d4cd925cdb79fd9d7cefd998f48 | |
| ToppCell | LAM-Lymphoid-NK|LAM / Condition, Lineage and Cell class | 7.87e-05 | 195 | 52 | 4 | 229374c72acef32b0e915379bdf3c82f351940e2 | |
| ToppCell | 3'-Parenchyma_lung-Immune_Lymphocytic-Lymphocytic_T/NK|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 8.03e-05 | 196 | 52 | 4 | a2607e972ff11d2e2fb8359e39605c236c0a1c63 | |
| ToppCell | facs-Trachea-24m-Mesenchymal-fibroblast-fibroblast_of_trachea-tracheal_fibroblast_l20-25|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 8.03e-05 | 196 | 52 | 4 | ed6047b48b6a96baa6a90c7af784e7c34b32824d | |
| ToppCell | cellseq-Immune-Lymphocytic_T/NK-Lymphocytic_T/NK-NK|cellseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 8.19e-05 | 197 | 52 | 4 | 9eb81248299307203868b913b7d365e5ab1cbd60 | |
| ToppCell | Parenchymal-NucSeq-Epithelial-Epi_airway_secretory|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 8.35e-05 | 198 | 52 | 4 | af399569c718f5fd971d73a7926768c9311002a3 | |
| ToppCell | distal-2-Hematologic-Natural_Killer|2 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 8.51e-05 | 199 | 52 | 4 | 77cc79c612c56022b37c8f690363c9ac8776e9cf | |
| ToppCell | medial-Hematologic-Natural_Killer|medial / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 8.51e-05 | 199 | 52 | 4 | 4a75ef6a3b7b5d779a08d039a79322cd60b4ef65 | |
| ToppCell | distal-Hematologic-Natural_Killer-2|distal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 8.51e-05 | 199 | 52 | 4 | 928b152f3bade90dfdb15e46aaa0c85063db0026 | |
| ToppCell | Mild_COVID-19-T/NK-CD8+_T|Mild_COVID-19 / Disease group,lineage and cell class （2021.01.30） | 8.51e-05 | 199 | 52 | 4 | 27a1b62e270cad1defa80f04f4ee5b5c8e448792 | |
| ToppCell | Tracheal-10x3prime_v2-Immune_Lymphocytic-T-T_CD8-CD8_CTL|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations | 8.51e-05 | 199 | 52 | 4 | 7c63c389c914f1ef2fa92fa153f9ecf1087b8e31 | |
| ToppCell | medial-2-Hematologic-Natural_Killer|2 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 8.51e-05 | 199 | 52 | 4 | 52338b8970fba0b32578748ba0bec0b344171ca6 | |
| ToppCell | medial-Hematologic-Natural_Killer-2|medial / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 8.51e-05 | 199 | 52 | 4 | dfcc4976688c7e6df5e41ae77436710075f1f779 | |
| ToppCell | Tracheal-10x3prime_v2-Immune_Lymphocytic-NK-ILC-T_NK-NK|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations | 8.51e-05 | 199 | 52 | 4 | dfb89ff7b075420c63ead0f802d93a5f82fb7c28 | |
| ToppCell | Tracheal-10x3prime_v2-Immune_Lymphocytic-NK-ILC|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations | 8.68e-05 | 200 | 52 | 4 | 993b0856964d611af8d8cd1ea4d609fa3ede65ea | |
| ToppCell | Tracheal-NucSeq-Immune_Lymphocytic-T-T_CD4|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 8.68e-05 | 200 | 52 | 4 | d8459e45a8396a9ee063666a1928c649162c5727 | |
| ToppCell | Hematolymphoid-Endothelial-NOSTRIN|Hematolymphoid / cells hierarchy compared to all cells using T-Statistic | 8.68e-05 | 200 | 52 | 4 | 032df80aa5c40991e1c1e80f9d8da106e6aeaee2 | |
| ToppCell | cellseq-Immune-Lymphocytic_T/NK-Lymphocytic_T/NK|cellseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 8.68e-05 | 200 | 52 | 4 | 3b5f76a1f7b1ef6820742345af61d7afd0d73f41 | |
| ToppCell | Biopsy_Control_(H.)-Immune-NK_cells|Biopsy_Control_(H.) / Sample group, Lineage and Cell type | 8.68e-05 | 200 | 52 | 4 | c93393d52ed1c238d539f254fd2a95eb101a6f65 | |
| ToppCell | cellseq-Immune-Lymphocytic_T/NK|cellseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 8.68e-05 | 200 | 52 | 4 | 73c99af6347f3b4e427b128f99ecb2da1a95e6ed | |
| ToppCell | Hematolymphoid-Endothelial-NOSTRIN---|Hematolymphoid / cells hierarchy compared to all cells using T-Statistic | 8.68e-05 | 200 | 52 | 4 | 68fce28690246895fd33354b30960ebcc31aa4cc | |
| ToppCell | Hematolymphoid-Endothelial-NOSTRIN-|Hematolymphoid / cells hierarchy compared to all cells using T-Statistic | 8.68e-05 | 200 | 52 | 4 | 376b19ab5a7cd2c85f726d8ba41337d4525863e5 | |
| ToppCell | Parenchymal-10x3prime_v2-Immune_Lymphocytic-NK-ILC|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations | 8.68e-05 | 200 | 52 | 4 | 48131c7c9444af84afb23184382d82e850acb445 | |
| ToppCell | Parenchymal-10x3prime_v2-Immune_Lymphocytic-T-T_CD8-CD8_CTL|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations | 8.68e-05 | 200 | 52 | 4 | 641c875ab1403e02d5d47a6f645d27273c2ee056 | |
| ToppCell | Bronchial-10x5prime-Immune_Lymphocytic-NK-ILC-T_NK|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 8.68e-05 | 200 | 52 | 4 | b4d956067eb292cf2855c674d1eb05a5f2d988f7 | |
| ToppCell | Parenchymal-10x3prime_v2-Immune_Lymphocytic-T-T_CD8|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations | 8.68e-05 | 200 | 52 | 4 | df91f220a9dbde91d77317f3e837654bd7989e47 | |
| ToppCell | Tracheal-NucSeq-Immune_Lymphocytic-T-T_CD8|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 8.68e-05 | 200 | 52 | 4 | 13d8c5d65d7f900979319433e7044efa6d06de20 | |
| ToppCell | distal-Hematologic-Natural_Killer|distal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 8.68e-05 | 200 | 52 | 4 | 33947befb9d32ec00f9f3e7eedaac478dcd63b20 | |
| ToppCell | Tracheal-10x3prime_v2-Immune_Lymphocytic-T|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations | 8.68e-05 | 200 | 52 | 4 | ee5bb02fad48a77e3cc8c77cc086a1638764d580 | |
| ToppCell | Hematolymphoid-Endothelial-NOSTRIN--|Hematolymphoid / cells hierarchy compared to all cells using T-Statistic | 8.68e-05 | 200 | 52 | 4 | 7fa54370221ed61bac0e09e6bcf1f3dff202a846 | |
| ToppCell | Parenchymal-10x3prime_v2-Immune_Lymphocytic-NK-ILC-T_NK|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations | 8.68e-05 | 200 | 52 | 4 | 755d65be8f05d4bf37c5dbe54948d2d8ab357d30 | |
| ToppCell | Tracheal-NucSeq-Immune_Lymphocytic-T|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 8.68e-05 | 200 | 52 | 4 | dbbc7e16929e744b48017da068479a6046e99cf6 | |
| ToppCell | Tracheal-10x3prime_v2-Immune_Lymphocytic-NK-ILC-T_NK|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations | 8.68e-05 | 200 | 52 | 4 | 2efea0f2ac28d973182763d7667614204718d624 | |
| ToppCell | Bronchial-10x5prime-Immune_Lymphocytic-NK-ILC|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 8.68e-05 | 200 | 52 | 4 | c09bb5c994f098d86e873bd3f1d911b02563e6e2 | |
| ToppCell | distal-1-Hematologic-Natural_Killer|1 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 8.68e-05 | 200 | 52 | 4 | 69756eba4b9b6cd5115aa7b76dfc36bb70097993 | |
| ToppCell | Hematolymphoid-Endothelial-NOSTRIN----L2-6|Hematolymphoid / cells hierarchy compared to all cells using T-Statistic | 8.68e-05 | 200 | 52 | 4 | 878bbbe32e3602723aa14ef32877ab2453b8c6e5 | |
| ToppCell | Hematolymphoid-Endothelial|Hematolymphoid / cells hierarchy compared to all cells using T-Statistic | 8.68e-05 | 200 | 52 | 4 | 7136936d05ab344a560cf159684c881063b5430d | |
| Drug | Leflunomide [75706-12-6]; Down 200; 14.8uM; MCF7; HT_HG-U133A | 6.94e-05 | 192 | 51 | 5 | 6102_DN | |
| Drug | androstan-3-ol | 7.34e-05 | 6 | 51 | 2 | ctd:C000658 | |
| Drug | (S)-(-)-Atenolol [93379-54-5]; Up 200; 15uM; MCF7; HT_HG-U133A | 7.47e-05 | 195 | 51 | 5 | 5325_UP | |
| Drug | Urapidil hydrochloride [64887-14-5]; Up 200; 9.4uM; HL60; HT_HG-U133A | 7.47e-05 | 195 | 51 | 5 | 3078_UP | |
| Drug | Flupentixol dihydrochloride cis-(Z) [2413-38-9]; Up 200; 7.8uM; MCF7; HT_HG-U133A | 7.47e-05 | 195 | 51 | 5 | 2643_UP | |
| Drug | Retrorsine [480-54-6]; Up 200; 11.4uM; PC3; HT_HG-U133A | 7.65e-05 | 196 | 51 | 5 | 6601_UP | |
| Drug | Thiamine hydrochloride [67-03-8]; Up 200; 11.8uM; MCF7; HT_HG-U133A | 7.65e-05 | 196 | 51 | 5 | 7479_UP | |
| Drug | 3-nitropropionic acid; Down 200; 10uM; MCF7; HT_HG-U133A | 7.65e-05 | 196 | 51 | 5 | 6402_DN | |
| Drug | CP-645525-01 [287190-82-3]; Down 200; 10uM; MCF7; HT_HG-U133A | 7.84e-05 | 197 | 51 | 5 | 7522_DN | |
| Drug | Rapamycin; Up 200; 0.1uM; HL60; HT_HG-U133A | 7.84e-05 | 197 | 51 | 5 | 2667_UP | |
| Drug | Dehydrocholic acid [81-23-2]; Up 200; 9.6uM; MCF7; HT_HG-U133A | 7.84e-05 | 197 | 51 | 5 | 5681_UP | |
| Drug | Oxolinic acid [14698-29-4]; Up 200; 15.4uM; MCF7; HT_HG-U133A | 7.84e-05 | 197 | 51 | 5 | 5519_UP | |
| Drug | nifedipine; Down 200; 10uM; MCF7; HG-U133A | 8.22e-05 | 199 | 51 | 5 | 603_DN | |
| Drug | Edrophonium chloride [116-38-1]; Down 200; 19.8uM; MCF7; HT_HG-U133A | 8.42e-05 | 200 | 51 | 5 | 5001_DN | |
| Drug | Probucol [23288-49-5]; Up 200; 7.8uM; MCF7; HT_HG-U133A | 8.42e-05 | 200 | 51 | 5 | 5626_UP | |
| Drug | Tinidazole [19387-91-8]; Down 200; 16.2uM; MCF7; HT_HG-U133A | 8.42e-05 | 200 | 51 | 5 | 3896_DN | |
| Disease | Germ Cell Cancer | 2.68e-04 | 15 | 48 | 2 | C0740345 | |
| Disease | Germ cell tumor | 2.68e-04 | 15 | 48 | 2 | C0205851 | |
| Disease | Neoplasms, Embryonal and Mixed | 2.68e-04 | 15 | 48 | 2 | C0205852 | |
| Disease | Embryonal Neoplasm | 2.68e-04 | 15 | 48 | 2 | C0027654 | |
| Disease | Neoplasms, Germ Cell and Embryonal | 2.68e-04 | 15 | 48 | 2 | C0027658 | |
| Disease | Cancer, Embryonal | 2.68e-04 | 15 | 48 | 2 | C0751364 | |
| Disease | Cancer, Embryonal and Mixed | 2.68e-04 | 15 | 48 | 2 | C0751365 | |
| Disease | Disorder of eye | 3.93e-04 | 212 | 48 | 4 | C0015397 | |
| Disease | pathological myopia | 7.92e-04 | 111 | 48 | 3 | EFO_0004207 | |
| Disease | chloride measurement | 1.02e-03 | 29 | 48 | 2 | EFO_0009284 | |
| Disease | gestational age, parental genotype effect measurement | 1.49e-03 | 35 | 48 | 2 | EFO_0005112, EFO_0005939 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| APHPPTVLRPQLGLH | 16 | Q5TEZ4 | |
| QRHPNTHDRLPPGPR | 21 | P20813 | |
| PHLHPAPPRGPRLTR | 36 | O95076 | |
| VQERAEPPGHPHPLA | 51 | Q9UNA0 | |
| QAPSHRPPPPGHRVQ | 291 | P06729 | |
| THGIPQLPRVRPEHP | 1081 | Q5JTC6 | |
| HVPLPVTQLPAAPRG | 251 | Q96EG1 | |
| HRVRPGPVPHSQEPE | 16 | Q99767 | |
| PRRRHAPGTEPHVAP | 126 | Q495Z4 | |
| LVPTTHPGQPARHPA | 726 | P78325 | |
| HLPRPPTETPCNRHV | 926 | Q9UKP4 | |
| REHGHRDPNVVPGPP | 471 | Q76M96 | |
| RHVEQVLQRHGVPPP | 1451 | Q9H3S7 | |
| LQPARPVRHLTSPPG | 11 | P0DMB2 | |
| RRLPHPPIRHQVSTP | 926 | Q6PRD1 | |
| PVEHVPIPKGRHRGV | 81 | P38570 | |
| HGSLVRIPPPPAHER | 736 | O43526 | |
| APRHPHKGIPPLQDV | 706 | Q9H5P4 | |
| HHPEPIPRPTEGGVV | 161 | A8MZ36 | |
| PGIPPEQPHQRTLEH | 186 | Q8TE67 | |
| LETGIFPPGHHPRRV | 181 | Q9P2V4 | |
| VGRPIPVPQRLHPTE | 291 | Q86VF5 | |
| VRLPVSQNVHPPRGP | 1046 | Q14686 | |
| RGVHVPPPLHPAPAR | 56 | A0A2Z4LIS9 | |
| NFPVVRSLPPPVHRH | 1231 | Q711Q0 | |
| HHLPRQVRPGPVYKP | 126 | A6NFR6 | |
| PHAIRVQTPPRHIPG | 301 | Q9BQW3 | |
| RPHGLPQHPQRSPHP | 386 | Q9UPW0 | |
| HRPRPLHGLQQPQPP | 91 | P22004 | |
| PSRQPGSVPRHVSPV | 746 | Q13443 | |
| TPHAIRVQTPPRHIP | 306 | Q9UH73 | |
| TVHHRPPQVHTEPPR | 1121 | Q6VMQ6 | |
| VQAPPPVVNVRVHHP | 221 | Q9NS15 | |
| EVLEKPVHLPRPGHP | 2296 | O15021 | |
| TVHFGQVRPPRPHVV | 491 | Q8TEH3 | |
| HPLQRLRVPPPPHGA | 186 | P37088 | |
| TTHRPLHVQRPSIPP | 1706 | Q01668 | |
| HLNQGRPHLSPRPPP | 1021 | Q9NZ71 | |
| TAQPHAGTLPRPRPV | 786 | Q68EM7 | |
| RSPVPPSERHGVRPH | 221 | P0CK97 | |
| PPHPRGTEEPQVPLH | 816 | Q14940 | |
| PHGTRRHLPSPPLTQ | 1266 | Q07889 | |
| LRRHQRTHAGPPTPP | 221 | Q8N8E2 | |
| QIRPPFIRGPPHHAS | 406 | A7XYQ1 | |
| PRVTVPIPPTHRRVH | 946 | A6NE52 | |
| PHLHQMPRRVPLGPS | 1171 | Q96MS0 | |
| PAQRGKVPPVHHSSP | 166 | O60667 | |
| LPRTSHGPQVAVPVP | 786 | Q9NPG3 | |
| SPVQVPARAHGPVPR | 626 | Q5SXM2 | |
| SVILQPPLPHTPHGR | 926 | Q5SXM2 | |
| RGVHVPPPLHPAPAR | 56 | P0CG31 | |
| PRVPLPVAGHPHRIG | 401 | Q86XT4 | |
| QAREPGHPHLPRPPA | 306 | Q9NX94 | |
| PPASPGRPEQHTVIH | 186 | O95159 | |
| SRPSRIPQPVRHHPP | 2336 | O75962 | |
| IPQPVRHHPPVLVSS | 2341 | O75962 |